• Bortezomib and UCK2: Reading Proteostasis

  2026-09-29

  Bortezomib (PS-341) can do more than trigger apoptosis: it can help test how proteasomal turnover connects mTORC1 signaling with UCK2-dependent pyrimidine salvage. This guide translates recent mechanistic findings into better assay design and interpretation.

• Doxorubicin Beyond Cytotoxicity: A Translational Playbook

  2026-09-29

  Doxorubicin is more than a canonical cancer chemotherapy drug: it is a mechanistic stress test for DNA damage, chromatin disruption, apoptosis, and treatment-limiting cardiotoxicity. This thought-leadership guide connects Adriamycin exposure design with the NRF2–HIPK2 findings reported for aucubin, helping translational researchers build more informative efficacy and safety workflows.

• IBDV VP3 Disrupts IRF7 Antiviral Signaling

  2026-09-28

  The reference study identifies a mechanism by which very virulent infectious bursal disease virus suppresses chicken IRF7-mediated type I interferon responses. Its central finding is that the viral VP3 protein interacts with IRF7 and promotes its proteasome-associated degradation, thereby reducing IFN-β expression and supporting viral replication.

• Cy3 Goat Anti-Human IgG (H+L) Antibody: Workflows

  2026-09-28

  Build practical fluorescence workflows for visualizing human IgG in cells, tissue sections, flow samples, and fluorescence-compatible ELISA. This guide connects assay design to orthopoxvirus antibody research while clarifying a key limitation: an anti-human secondary detects human IgG, not the mouse-derived antibodies described in the reference study.

• Mubritinib (TAK 165): Mitochondrial Stress in NSCLC

  2026-09-27

  Mubritinib (TAK 165) is best understood in this lung-cancer study as a mitochondrial stressor, not simply a historical HER2 inhibitor. Explore how evidence for cisplatin sensitization informs assay design, mechanistic interpretation, and the limits of translating results between cancer models.

• Estradiol Workflows for Receptor–Autophagy Research

  2026-09-26

  Use 17 beta-estradiol to probe receptor-dependent gene regulation and test how estrogen receptor signaling connects with autophagy in vascular and multi-organ models. This practical guide separates published findings from suggested starting conditions for dosing, controls, readouts, and troubleshooting.

• Cy3 Goat Anti-Human IgG: From Signal to Evidence

  2026-09-25

  The Cy3 Goat Anti-Human IgG (H+L) Antibody can make human IgG visible, but fluorescence alone does not establish antibody function. Explore how to pair this Cy3 conjugated secondary antibody with species-aware assay design and orthopoxvirus antibody research.

• CHK1 Inhibition in Breast Cancer: ER/PR Shape Response

  2026-09-25

  This study shows that checkpoint kinase 1 (CHK1) inhibition has different effects across hormone-receptor-defined breast cancer models: it enhances adriamycin sensitivity in ER−/PR−/HER2− cells, but not in ER+/PR+/HER2− cells. The latter models nevertheless show single-agent responses, underscoring why receptor status and treatment context should be built into CHK1-inhibitor study design.

• Vincristine Sulfate: From Mechanism to Translation

  2026-09-24

  A translational framework for using vincristine sulfate to connect tubulin-level activity with cancer-model evidence—while keeping experimental findings, model context, and clinical relevance distinct.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide

  2026-09-24

  Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat IgG primary antibodies in ICC/IF, IHC, flow cytometry, and ELISA workflows. It is not a universal secondary: do not use it to detect primaries from other host species, and validate assay conditions and fluorescence controls before relying on a signal.

• Isoprenaline Hydrochloride in Heart–Brain Research

  2026-09-23

  Isoprenaline Hydrochloride, also known as isoproterenol, is a non-selective β-adrenoceptor agonist used to investigate cardiac and vascular responses. A 2026 mouse study used chronic isoproterenol to examine how sympathetic cardiac overactivation relates to insular cortex activity and PTSD-like behaviors, while also identifying important limits on interpreting this model.

• From Antibody Maps to Translational Assays

  2026-09-23

  How mechanistic epitope mapping, human IgG detection, and assay design can connect orthopoxvirus antibody discovery with translational research decisions.

• 3-Deazaneplanocin: Mechanism-Led Assay Design

  2026-09-22

  3-Deazaneplanocin (DZNep) is more than a broad epigenetic modulator: its SAHH inhibition and EZH2 suppression create a context-dependent response profile. This guide translates AML, HCC, metabolic, and breast-cancer research insights into better assay decisions and interpretation.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide

  2026-09-22

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat IgG primary antibodies in ICC/IF, tissue staining, flow cytometry, and compatible ELISA workflows. It should not be used as a universal secondary antibody or with non-goat primary antibodies, and assay-specific dilution, controls, and spectral validation remain necessary.

• Cy3 Goat Anti-Human IgG (H+L) Antibody Workflow

  2026-09-21

  Build sensitive, reproducible human-IgG detection workflows for immunofluorescence assay, immunohistochemistry, flow cytometry, and ELISA. This practical guide connects Cy3 optical performance and secondary-antibody signal amplification with assay controls, tissue handling, and antibody-development research.

8155 records 1/544 page Next 12345 下5页 Last page